難治性唾液腺癌に対する次世代抗体医薬開発へ向けた創薬基盤研究

• Project/Area Number: 25K12794
• Research Category: Grant-in-Aid for Scientific Research (C)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 56050:Otorhinolaryngology-related
• Research Institution: Nagoya City University
• Principal Investigator: 川北 大介 名古屋市立大学, 医薬学総合研究院(医学), 准教授 (70584506)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2027: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000); Fiscal Year 2026: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000); Fiscal Year 2025: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)